Subtopic Deep Dive
Estimated Glomerular Filtration Rate
Research Guide
What is Estimated Glomerular Filtration Rate?
Estimated Glomerular Filtration Rate (eGFR) is a calculated measure of kidney function using serum creatinine or cystatin C levels in equations like MDRD and CKD-EPI to stage chronic kidney disease.
eGFR equations estimate true GFR non-invasively for CKD staging and risk assessment. Key formulations include MDRD (Levey et al., 2005, 3856 citations) and CKD-EPI refinements (Inker et al., 2014, 1784 citations). Over 6000 papers reference eGFR in global CKD burden analyses (Bikbov et al., 2020, 6137 citations).
Why It Matters
Accurate eGFR guides CKD staging, therapy decisions like empagliflozin use (Herrington et al., 2022, 2087 citations), and diabetes management (Thomas et al., 2015, 1126 citations). Global prevalence studies rely on eGFR for burden estimates affecting 10% of adults (Hill et al., 2016, 3820 citations). Myers (2005, 1221 citations) highlights how creatinine assay standardization improves eGFR precision worldwide.
Key Research Challenges
Bias in creatinine-based equations
MDRD and CKD-EPI equations show bias in normal GFR ranges and diverse populations due to creatinine variability (Myers, 2005). Standardization efforts reduce errors but race and muscle mass factors persist (Inker et al., 2014). Cystatin C integration addresses some biases.
Race-free eGFR formulation validation
Traditional equations include race coefficients questioned for equity (Levey et al., 2005). New race-free CKD-EPI versions require multi-ethnic validation (Inker et al., 2014). Global studies like Bikbov et al. (2020) underscore need for universal applicability.
Integration with diabetes CKD progression
eGFR decline predicts diabetic kidney disease outcomes but varies by glycemic control (Thomas et al., 2015). Trials like empagliflozin show eGFR slopes as endpoints (Herrington et al., 2022). Harmonizing equations across comorbidities remains unresolved.
Essential Papers
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov, Caroline Purcell, Andrew S. Levey et al. · 2020 · The Lancet · 6.1K citations
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Lee A. Hebert, Samir M. Parikh, Jason Prosek et al. · 2013 · American Journal of Nephrology · 4.4K citations
<b><i>Background:</i></b> Glomerular disease is a complex and evolving topic. In evaluating a specific case it is not unusual for the clinician to ask: ‘Am I missing somethi...
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · 2005 · Kidney International · 3.9K citations
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Nathan R. Hill, Samuel Fatoba, Jason Oke et al. · 2016 · PLoS ONE · 3.8K citations
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associat...
Chronic Kidney Disease
Angela C Webster, Evi Nagler, Rachael L. Morton et al. · 2016 · The Lancet · 3.6K citations
Empagliflozin in Patients with Chronic Kidney Disease
William G. Herrington · 2022 · New England Journal of Medicine · 2.1K citations
Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiov...
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
Lesley A. Inker, Brad C. Astor, Chester H. Fox et al. · 2014 · American Journal of Kidney Diseases · 1.8K citations
Reading Guide
Foundational Papers
Start with Levey et al. (2005, 3856 citations) for CKD definition using eGFR; Myers (2005, 1221 citations) for creatinine standardization impacting all equations; Inker et al. (2014, 1784 citations) for US KDIGO adaptations.
Recent Advances
Herrington et al. (2022, 2087 citations) shows eGFR slopes in CKD trials; Bikbov et al. (2020, 6137 citations) for global eGFR-based burden.
Core Methods
MDRD equation (Levey 2005); CKD-EPI refinements (Inker 2014); cystatin C for reduced bias; IDMS-traceable creatinine assays (Myers 2005).
How PapersFlow Helps You Research Estimated Glomerular Filtration Rate
Discover & Search
Research Agent uses searchPapers and exaSearch to find eGFR equation validations, revealing citationGraph clusters around Levey et al. (2005) with 3856 citations. findSimilarPapers expands from Bikbov et al. (2020) to global burden papers.
Analyze & Verify
Analysis Agent applies readPaperContent to extract MDRD bias data from Myers (2005), then runPythonAnalysis on creatinine datasets for statistical verification. verifyResponse with CoVe and GRADE grading assesses eGFR equation claims for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in race-free eGFR adoption post-Inker (2014), flags contradictions in cystatin C papers. Writing Agent uses latexEditText, latexSyncCitations for CKD guideline drafts, latexCompile for publication-ready reports with exportMermaid for eGFR decline flowcharts.
Use Cases
"Analyze bias in MDRD equation using provided creatinine data"
Research Agent → searchPapers(MDRD bias) → Analysis Agent → readPaperContent(Myers 2005) → runPythonAnalysis(pandas bias regression) → matplotlib plot of GFR errors.
"Draft LaTeX review on race-free eGFR in diabetes CKD"
Synthesis Agent → gap detection(Inker 2014, Thomas 2015) → Writing Agent → latexEditText(section on validations) → latexSyncCitations(20 papers) → latexCompile(PDF review with diagrams).
"Find code for eGFR calculation from recent papers"
Research Agent → searchPapers(eGFR calculator code) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(python eGFR scripts) → exportCsv(formula implementations).
Automated Workflows
Deep Research workflow conducts systematic eGFR equation review: searchPapers(50+ hits) → citationGraph → DeepScan(7-step bias analysis with CoVe checkpoints) → structured GRADE-graded report. Theorizer generates hypotheses on cystatin C superiority from Levey (2005) and Herrington (2022) endpoints. DeepScan verifies global applicability claims in Bikbov (2020).
Frequently Asked Questions
What is eGFR?
eGFR estimates kidney function from serum creatinine using MDRD or CKD-EPI equations (Levey et al., 2005). Stages CKD from G1 (>90 mL/min) to G5 (<15 mL/min).
What are main eGFR methods?
Creatinine-based: MDRD, CKD-EPI; cystatin C-based alternatives (Inker et al., 2014). Standardization per Myers (2005) is critical.
What are key papers on eGFR?
Levey et al. (2005, 3856 citations) defines CKD staging; Inker et al. (2014, 1784 citations) comments on KDIGO guidelines; Myers (2005, 1221 citations) on creatinine measurement.
What are open problems in eGFR research?
Race-free equation validation across populations; bias reduction in diabetes (Thomas et al., 2015); integration with SGLT2i trial endpoints (Herrington et al., 2022).
Research Chronic Kidney Disease and Diabetes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Estimated Glomerular Filtration Rate with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers